Augmenter of liver regeneration (ALR) protects human hepatocytes against apoptosis

Biochemical and Biophysical Research Communications

Volumn 404, Issue 1, 2011, Pages 148-152

  Ilowski, Maren ^a   Kleespies, Axel ^a   de Toni, Enrico N ^a   Donabauer, Barbara ^a   Jauch, Karl Walter ^a   Hengstler, Jan G ^b   Thasler, Wolfgang E ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

Author keywords

Anti apoptosis; Augmenter of liver regeneration; Hepatotrophic growth factor; Human hepatocytes; Liver cell protection; Liver regeneration

Indexed keywords

ALCOHOL; APOLIPOPROTEIN ANTIBODY; CYTOCHROME C; DACTINOMYCIN; MITOGENIC AGENT; PROPIDIUM IODIDE; PROTEIN ANTIBODY; RECOMBINANT AUGMENTER OF LIVER REGENERATION; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BRONCHUS; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN HEPG2; COLON; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER MITOCHONDRION; LIVER PROTECTION; LIVER REGENERATION; PANCREAS; PRIORITY JOURNAL; STOMACH; TUMOR CELL;

APOPTOSIS; CELL LINE; CYTOCHROME REDUCTASES; CYTOCHROMES C; CYTOPROTECTION; HEPATOCYTES; HUMANS; MITOCHONDRIA, LIVER;

EID: 78650916352     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.11.083     Document Type: Article

References (32)

1. Gazit V., Weymann A., Hartman E., et al. Liver regeneration is impaired in lipodystrophic fatty liver dystrophy mice. Hepatology 2010, 52:2109-2117.
2. Iimuro Y., Fujimoto J. TLRs, NF-kappaB, JNK and liver regeneration gastroenterol. Res. Pract. 2010, 10.1155/2010/598109.
3. Hambruch N., Haeger J.D., Dilly M., et al. EGF stimulates proliferation in the bovine placental trophoblast cell line F3 via Ras and MAPK. Placenta 2010, 31:67-74.
4. Li J., Reed S.A., Johnson S.E. Hepatocyte growth factor (HGF) signals through SHP2 to regulate primary mouse myoblast proliferation. Exp. Cell Res. 2009, 315:2284-2292.
5. Daithankar V.N., Farrell S.R., Thorpe C. Augmenter of liver regeneration: substrate specificity of a flavin-dependent oxidoreductase from the mitochondrial intermembrane space. Biochemistry 2009, 48:4828-4837.
6. Yang X., Wang A., Zhou P., et al. Protective effect of recombinant human augmenter of liver regeneration on CCl4-induced hepatitis in mice. Chin. Med. J. (Engl.) 1998, 111:625-629.
7. Tzirogiannis K.N., Papadimas G.K., Kourentzi K.T., et al. The role of hepatic stimulator substance (HSS) on liver regeneration arrest induced by cadmium. In Vivo 2005, 19:695-704.
8. Ilowski M., Putz C., Weiss T.S., et al. Augmenter of liver regeneration causes different kinetics of ERK1/2 and Akt/PKB phosphorylation than EGF and induces hepatocyte proliferation in an EGF receptor independent and liver specific manner. Biochem. Biophys. Res. Commun. 2010, 394:915-920.
9. Malhi H., Guicciardi M.E., Gores G.J. Hepatocyte death: a clear and present danger. Physiol. Rev. 2010, 90:1165-1194.
10. Schulze-Bergkamen H., Brenner D., Krueger A., et al. Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt. Hepatology 2004, 39:645-654.
11. Li-juan B., Bing L., Zhi L., et al. Hepatocyte growth factor suppresses tumor cell apoptosis in nasopharyngeal carcinoma by upregulating Bcl-2 protein expression. Pathol. Res. Pract. 2009, 205:828-837.
12. Li W., Cai S., Cai L., et al. Anti-apoptotic effect of hepatocyte growth factor from actinomycin D in hepatocyte-derived HL7702 cells is associated with activation of PI3K/Akt signaling. Toxicol. Lett. 2006, 165:142-148.
13. Yang H., Magilnick N., Xia M., et al. Effects of hepatocyte growth factor on glutathione synthesis, growth, and apoptosis is cell density-dependent. Exp. Cell Res. 2008, 314:398-412.
14. Valdes-Arzate A., Luna A., Bucio L., et al. Hepatocyte growth factor protects hepatocytes against oxidative injury induced by ethanol metabolism. Free Radic. Biol. Med. 2009, 47:424-430.
15. Tei N., Tsujihata M., Tsujikawa K., et al. Hepatocyte growth factor has protective effects on crystal-cell interaction and crystal deposits. Urology 2006, 67:864-869.
16. Thasler W.E., Schlott T., Thelen P., et al. Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma. Histopathology 2005, 47:57-66.
17. Dayoub R., Thasler W.E., Bosserhoff A.K., et al. Regulation of polyamine synthesis in human hepatocytes by hepatotrophic factor augmenter of liver regeneration. Biochem. Biophys. Res. Commun. 2006, 345:181-187.
18. Thasler W.E., Weiss T.S., Schillhorn K., et al. Charitable state-controlled foundation human tissue and cell research: ethic and legal aspects in the supply of surgically removed human tissue for research in the academic and commercial sector in Germany. Cell Tissue Bank 2003, 4:49-56.
19. Weiss T.S., Pahernik S., Scheruebl I., et al. Cellular damage to human hepatocytes through repeated application of 5-aminolevulinic acid. J. Hepatol. 2003, 38:476-482.
20. van den Engel N.K., Winter H., Ruttinger D., et al. Characterization of immune responses in gastric cancer patients A possible impact of H. pylori to polarize a tumor-specific type 1 response?. Clin. Immunol. 2006, 120:285-296.
21. Klingmüller U., Bauer A., Bohl S., et al. Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modeling of signal transduction pathways. syst. Biol. (stevenage) 2006, 153:433-477.
22. Nicoletti I., Migliorati G., Pagliacci M.C., et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 1991, 139:271-279.
23. Guicciardi M.E., Gores G.J. Apoptosis as a mechanism for liver disease progression. Semin. Liver Dis. 2010, 30:402-410.
24. Jo M., Kim T.H., Seol D.W., et al. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat. Med. 2000, 6:564-567.
25. Lavrik I.N., Golks A., Riess D., et al. Analysis of CD95 threshold signaling: triggering of CD95 (FAS/APO-1) at low concentrations primarily results in survival signaling. J. Biol. Chem. 2007, 282:13664-13671.
26. Godoy P., Hengstler J.G., Ilkavets I., et al. Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor beta-induced apoptosis. Hepatology 2009, 49:2031-2043.
27. Polimeno L., Pesetti B., Lisowsky T., et al. Protective effect of augmenter of liver regeneration on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells. Free Radic. Res. 2009, 43:865-875.
28. Liao X.H., Zhang L., Liu Q., et al. Augmenter of liver regeneration protects kidneys from ischaemia/reperfusion injury in rats. Nephrol. Dial. Transplant. 2010, 25:2921-2929.
29. Zhang L.M., Liu D.W., Liu J.B., et al. Effect of naked eukaryotic expression plasmid encoding rat augmenter of liver regeneration on acute hepatic injury and hepatic failure in rats. World J. Gastroenterol. 2005, 11:3680-3685.
30. Tanigawa K., Sakaida I., Masuhara M., et al. Augmenter of liver regeneration (ALR) may promote liver regeneration by reducing natural killer (NK) cell activity in human liver diseases. J. Gastroenterol. 2000, 35:112-119.
31. Thirunavukkarasu C., Wang L.F., Harvey S.A., et al. Augmenter of liver regeneration: an important intracellular survival factor for hepatocytes. J. Hepatol. 2008, 48:578-588.
32. Cao Y., Fu Y.L., Yu M., et al. Human augmenter of liver regeneration is important for hepatoma cell viability and resistance to radiation-induced oxidative stress. Free Radic. Biol. Med. 2009, 47:1057-1066.